Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications
Overview
This study has for objective to collect medical data from patients with uterine rupture at the childbirth.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: December 2013
Detailed Description
This is a retrospective study, gathering data of five maternity in the department of Val d'Oise in France, during 13 years (between 01/01/2000 an 31/12/2013). The incidence of uterine rupture increases with increasing cesarean rates. It occurs at a rate of 0.08% across all childbirths in France, and 0.5 to 1% of the childbirths on cicatricial uterus in France. Although the risk factors are known, it is usually unexpected. This is a serious complication for the mother (mortality <1%, severe morbidity at 15% ) and for the child (mortality for 3 to 6 % for childbirth at term, neonatal asphyxia for 6 to 15%) that can occur during pregnancy or during labor.
Interventions
- Other: Childbirth with uterine rupture
- No intervention. Follow-up of women with rupture uterine at the childbirth.
Arms, Groups and Cohorts
- Childbirth with uterine rupture
- No intervention. Follow-up of women with uterine rupture at the childbirth.
Clinical Trial Outcome Measures
Primary Measures
- Identify maternal and foetal risk factors associated to an uterine rupture ; by the report of events during pregnancy, pathology, lifestyle, Concomitant pathology…
- Time Frame: 1 day
Secondary Measures
- Number of maternal and foetal adverse events associated to an uterine rupture at the childbirth.
- Time Frame: 1 day
Participating in This Clinical Trial
Inclusion Criteria
- Childbirth with uterine rupture Exclusion Criteria:
- Childbirth in a maternity which do not participate to the study
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Hôpital NOVO
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- MARKOU Georges, PH, Principal Investigator, CH Rene Dubos, Pontoise
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.